Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 11975029
Compositions and methods for inhibition of lineage specific proteins
granted -
US 11976100
Methods for treating myelin associated diseases and mitochondria associated diseases
granted -
US 11974988
Neuroprotective compositions and methods of using the same
granted -
US 11974989
Therapeutic uses of glucokinase activators in combination with insulin or insulin analogs
granted -
US 11975047
Methods for storing and warming purified corticotropin compositions
granted -
US 11975028
Restimulation of cryopreserved tumor infiltrating lymphocytes
granted -
CN 117980330
Homodimeric peptides and antibodies comprising same
granted -
US 11969511
Methods and compositions for antimicrobial treatment
granted -
US 11970521
Neuroprotective beta amyloid core peptides and peptidomimetic derivatives
granted -
US 11970502
Macrocyclic antiviral agents
granted -
US 11969444
Restimulation of cryopreserved tumor infiltrating lymphocytes
granted -
US 11970553
Heterotandem bicyclic peptide complex
granted -
US 11969466
Stabilized influenza hemagglutinin stem region trimers and uses thereof
granted -
US 11969401
Compositions and methods for treating or limiting development of age-related macular degeneration
granted -
US 11970483
Heterocyclic compound
granted -
US 11969499
Hydrogel delivery of sting immunotherapy for treatment cancer
granted -
US 11969470
Topiramate compositions and methods of making and using the same
granted -
US 11969475
Muscle targeting complexes and uses thereof for treating facioscapulohumeral muscular dystrophy
granted -
US 11969408
Method for improving mitophagy in subjects
granted -
US 11970479
3-(1H-pyrazol-4-yl)pyridine allosteric modulators of the M4 muscarinic acetylcholine receptor
granted -
US 11970538
Multispecific binding constructs against checkpoint molecules and uses thereof
granted -
US 11969501
Auris formulations for treating otic diseases and conditions
granted -
US 11969522
Use of immune modulators to improve nerve regeneration
granted -
US 11970711
Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.